Inovio Pharma (INO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Sales | 6,145 | 9,120 | 2,098 | 4,808 | 3,468 |
| Gross Profit | 6,145 | 9,120 | 2,098 | 4,808 | 3,468 |
| Operating Expenses | 25,365 | 23,078 | 15,756 | 20,706 | 16,814 |
| Operating Income | -19,220 | -13,958 | -13,659 | -15,898 | -13,346 |
| Other Income | 1,581 | -10,501 | 693 | 4,694 | 1,002 |
| Pre-tax Income | -17,639 | -24,459 | -12,966 | -11,204 | -12,344 |
| Net Income Continuous | -17,639 | -24,459 | -12,966 | -11,204 | -12,344 |
| Minority Interests | -25 | -47 | N/A | N/A | N/A |
| Net Income | $-17,614 | $-24,412 | $-12,966 | $-11,204 | $-12,344 |
| EPS Basic Total Ops | -8.16 | -15.85 | -14.41 | -12.97 | -22.09 |
| EPS Basic Continuous Ops | -8.21 | -15.72 | -14.18 | -12.97 | -18.81 |
| EPS Diluted Total Ops | -8.16 | -15.85 | -14.41 | -12.97 | -22.09 |
| EPS Diluted Continuous Ops | -8.21 | -15.72 | -14.18 | -12.97 | -18.81 |
| EBITDA(a) | $-17,112 | $-12,281 | $-12,665 | $-14,944 | $-12,435 |